Lightchain Capital is a St. Louis-based family office and venture investor associated with Scottrade founder Rodger Riney. It focuses on U.S. early-stage life sciences and software companies, with particular emphasis on biotechnology, oncology, pharmaceuticals, and treatments for multiple myeloma and related cancers. The firm is also relevant for diagnostics, therapeutics, and other healthcare companies raising Series A through later-stage venture rounds.